FDA clears ‘Selux NGP System’ for rapid Antibiotic Susceptibility Testing
Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its proprietary Next Generation Phenotyping (NGP) System – a rapid antibiotic susceptibility (AST) testing platform that provides targeted therapeutic results days faster than the […]
